Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,000
NCT00021502
Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2001
Completion: May 31, 2004